Trophoblast stem cell marker gene expression in inner cell mass-derived cells from parthenogenetic equine embryos.

This study explores how-marker genes from stem cells in a type of tissue in horse embryos forms. It tests whether cells can be developed from two types of embryos: those created without fertilization and those made by replacing a cell’s nucleus. The researchers aim to create tailor-made stem cell lines for medical treatment experiments in horses. Findings reveal that using some tools to remove specific cells can lead to more harvested cells. The harvested cells expressed certain genetic markers. After a while, some of these cells stopped expressing one of those markers. The data suggests that these cells are trophoblast stem cells, which contribute to forming a fetus’s extra-embryonic tissue. The study concludes by noting its significance in creating tailor-made horse stem-cell lines for medical experiments.

Objective of the Research

• The researchers aimed to determine whether cell lines similar to embryonic stem cells (ESCs) could be developed from a type of embryo made without fertilization (parthenogenetic) and another type which is created by replacing the nucleus of a somatic cell (SCNT).
• The idea was to create tailor-made ESCs for cell treatment experiments in horses. They would do this by understanding how early-stage blastocysts with a visible inner cell mass could be used in combination with pronase (an enzyme mixture).

Process and Findings

• The researchers observed that using early-stage blastocysts and pronase allowed for a higher proportion of primary ICM outgrowths from SCNT and PA embryos.
• The primary ICM outgrowths expressed POU5F1 and SOX2, markers of pluripotency, which is the capability of a cell to differentiate into different cell types. Some cells also expressed NANOG, another important marker of pluripotency.
• Cells taken after the passages of PA primary ICM outgrowths displayed another marker, alkaline phosphatase (AP) activity, and continued with POU5F1 and SOX2 expressions. Expressions of CDX2 and EOMES were also observed, but NANOG expression may be lost.
• Cystic embryoid body-like structures expressing POU5F1, CDX2, and EOMES were produced from these cells.

Conclusion from the Study

• An immunohistochemical analysis of the equine embryos shows the POU5F1 marker in trophectoderm, primitive endoderm, and the inner cell mass (ICM).
• These results imply that the cells obtained after passages of primary ICM outgrowths are trophoblast stem cells, expressing POU5F1 and displaying AP activity, rather than true ESCs.
• The study contributes significantly to producing tailor-made equine ESCs for cell treatment studies, providing a path to pre-clinical studies in larger animal models.